Rare diseases
Investigational molecules
Locations
Back to Germany128 clinical trials in Greifswald, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis
GermanyA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
GermanyA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
GermanyA Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is
GermanyRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
GermanyA Study of ABBV-706 to Assess Safety and Efficacy Compared with Standard Drug Combination in Adults with Relapsed or Refractory Small Cell Lung Cancer
GermanyCevostamab plus pomalidomide and dexamethasone in patients with multiple myeloma previously treated with BCMA‑targeted CAR T‑cell therapy
GermanyCevostamab, Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma Previously Treated with 1‑3 Lines of Therapy
GermanyAccelerating improvement with teclistamab plus standard drug combination in newly diagnosed transplant‑eligible multiple myeloma patients
GermanyA study to evaluate the effectiveness and safety of REGN13335 in adults with pulmonary arterial hypertension
GermanyA study to evaluate the safety and effectiveness of inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease
GermanyA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on hematologic malignancies and solid tumors, including innovative studies for acute myeloid leukemia and B-cell lymphoma. Novel therapeutic approaches combine targeted treatments with immunotherapy.
Research emphasizes personalized medicine approaches and combination therapies for improved patient outcomes.
Comprehensive studies addressing various types of migraine conditions, including breakthrough treatments for episodic and menstrual migraine. Advanced research in dementia diagnostics and management.
Focus on developing innovative therapeutic solutions for better patient care and quality of life.
Cutting-edge research in pulmonary arterial hypertension, exploring new treatment options and combination therapies. Studies evaluate both oral and inhaled medications for optimal disease management.
Emphasis on improving patient outcomes through innovative therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
